Acelyrin Inc (SLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | SLRN | ERAS | QTTB | ||
Company | Acelyrin Inc | Erasca Inc | Q32 Bio Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 4.61 | 2.62 | 38.96 | ||
High | 4.96 | 2.85 | 40.00 | ||
Low | 4.52 | 2.60 | 38.30 | ||
Last | 4.79 | 2.75 | 39.49 | ||
Change | +0.25 | +0.01 | +0.91 | ||
% Change | +5.51% | +0.36% | +2.36% | ||
Volume | 1,055,700 | 1,589,800 | 153,300 | ||
20-Day Average Volume | 1,479,550 | 1,696,640 | 75,545 | ||
Previous Close | 4.54 | 2.74 | 38.58 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 5.01 | 2.75 | 37.46 | ||
20-Day Raw Stochastic | 38.44% | 42.86% | 79.77% | ||
20-Day Relative Strength | 46.85% | 51.44% | 65.03% | ||
Weighted Alpha | -66.16 | -4.44 | +124.44 | ||
Today's Opinion | 72% Sell | 80% Buy | 100% Buy | ||
Previous Opinion | 56% Sell | 72% Buy | 100% Buy | ||
Last Month's Opinion | 8% Buy | 100% Buy | 100% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +15.98% since 08/16/24 | -1.79% since 08/16/24 | +6.99% since 08/16/24 | ||
Low | 3.94 on 08/19/24 | 2.60 on 08/23/24 | 36.20 on 08/19/24 | ||
High | 5.13 on 08/20/24 | 2.91 on 08/21/24 | 40.98 on 08/21/24 | ||
1-Month | |||||
%Chg | -30.58% since 07/23/24 | -12.14% since 07/23/24 | +22.03% since 07/23/24 | ||
Low | 3.36 on 08/14/24 | 2.33 on 08/12/24 | 31.56 on 07/26/24 | ||
High | 7.10 on 07/26/24 | 3.45 on 07/26/24 | 42.98 on 07/25/24 | ||
3-Month | |||||
%Chg | +13.51% since 05/23/24 | +6.18% since 05/23/24 | +34.32% since 05/23/24 | ||
Low | 3.36 on 08/14/24 | 1.96 on 06/18/24 | 13.59 on 06/26/24 | ||
High | 7.25 on 07/17/24 | 3.45 on 07/26/24 | 42.98 on 07/25/24 | ||
6-Month | |||||
%Chg | -35.36% since 02/23/24 | +18.53% since 02/23/24 | +154.48% since 02/23/24 | ||
Low | 3.36 on 08/14/24 | 1.74 on 04/19/24 | 13.59 on 06/26/24 | ||
High | 8.89 on 03/01/24 | 3.45 on 07/26/24 | 42.98 on 07/25/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 474,339 | 476,737 | 471,590 | ||
Shares Outstanding, K | 99,027 | 173,359 | 11,942 | ||
Annual Sales | 0 | 0 | 1,160,000 | ||
Annual Net Income | -381,640,000 | -125,040,000 | -112,960,000 | ||
Last Quarter Sales | 0 | 0 | 0 | ||
Last Quarter Net Income | -85,670,000 | -63,200,000 | -16,980,000 | ||
60-Month Beta | 2.35 | 1.17 | -0.35 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.86 on 08/13/24 | -0.29 on 08/12/24 | -1.42 on 08/08/24 | ||
Latest Earnings Date | 08/13/24 | 08/08/24 | 08/12/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |